BNET Industries
Last Fiscal Year Sales:$27.3M
- Public
- US
Dow Jones Description
The New Tripos International helps pharmaceutical companies and research facilities around the world successfully accelerate the identification and optimization of new compounds that have the potential to become drug products. Headquartered in St. Louis, Missouri, Tripos International serves more than 1,000 customers spanning over 46 countries.
Number of Employees 327
Peer Companies
NAICS Code Custom Computer Programming Services: 541511
Recent Events
-
Tripos Releases Newest SYBYL-X Discovery Software for Computational Chemistry and Molecular Modeling
-
Tripos Releases Newest Version of Benchware Discovery 360 - Its Powerful, Enterprise-Wide, Pharmaceutical Research Softw
News & Analysis
Filter by
tripos inc. - All News and Analysis
Certara Names VP of European Sales
- 2009-06-12
Wireless News 06-12-2009 Certara Names VP of European Sales Type: News Certara, a global translational pharmacology company, formed by the acquisition of Pharsight Corp. by Tripos, announced the appointment of William Cobert to lead its European sales group. ...
Certara Names William Cobert as Vice President of European Sales for its Tripos and Pharsight Business Units
- 2009-06-09
International Sales Veteran to Lead Certaraâ??s Emerging Translational Pharmacology Business Group in Europe ST. LOUIS, Mo. -- Certaraâ?¢, a global, emerging translational pharmacology company, formed...
Company Profile for Tripos
- 2009-03-20
Tripos, a Certara Company, is a global leader in innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Established in 1979, Tripos was the...
Tripos Releases Muse – A New, Powerful Software Tool for Molecular Invention
- 2009-03-17
New Workflow Solution Inspires Discovery Scientists in Search for New Ideas ST....
European Molecular Biology Laboratory Signs Agreement to License Themis and Surflex-Dock Technologies from Tripos
- 2009-02-17
Tests Show Success in Rapid, Accurate Discovery of New Drug Possibilities ST. LOUIS, Mo. -- Tripos[TM], a leading provider of drug discovery informatics products and services, today announced an agreement with the European Molecular Biology Laboratory EMBL, Europe's leading research institution for molecular biology, to license Tripos' Themis[TM] and...
Tripos International Completes Acquisition of Pharsight Corporation
- 2008-11-03
ST. LOUIS -- Tripos International, the leading provider of drug discovery informatics products and services, today announced that it has completed the acquisition of Pharsight Corporation, a leader in software, strategic and regulatory services designed to optimize clinical drug development. The transaction, valued at approximately $57 million, moves Pharsight into...
Company Profile for The New Tripos International
- 2008-10-31
Tripos International is a global leader in innovative scientific solutions that enable life science researchers to improve the efficiency of their molecular discovery efforts. Established in 1979, Tripos was the first company to bring scientific computational drug discovery capabilities to the pharmaceutical, chemical and food design industries, and today helps...
Tripos International Announces Availability of its Popular SYBYL® Molecular Modeling Environment for the Mac
- 2008-10-29
Tripos' Widely Installed Discovery Research Software, SYBYL, is Now Available to an Even Broader Spectrum of Molecular Modeling Scientists Globally ST. LOUIS -- Tripos International, leading provider of drug discovery informatics products and services, today announced the release of its popular SYBYL software for Mac OS X Leopard. SYBYL,...
Tripos International Enters into Agreement to Collaborate on a Molecular Invention Workflow for Drug Discovery with AstraZeneca
- 2008-10-08
ST. LOUIS -- Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution. The centerpiece of the collaboration effort will be the development of Tripos' new Muse[TM] de novo design product, which...
Tripos International Enters Into Agreement to Collaborate on a Molecular Invention Workflow for Drug Discovery With AstraZeneca
- 2008-10-08
Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution. The centerpiece of the collaboration effort will be the development of Tripos' new MuseTM de novo design product, which is targeted for...
Industry Transcripts by Seeking Alpha
-
Blue Coat Systems, Inc. Q2 2010 Earnings Call Transcript
on Nov 24, 2009about BCSI
-
QAD Inc. F3Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about QADI
-
TiVo Inc. F3Q10 (Qtr End 10/31/2009) Earnings Call Transcript
on Nov 24, 2009about TIVO
-
Brocade Communications Systems Inc. F4Q09 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about BRCD
-
Analog Devices, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 23, 2009about ADI
Glass Door
Technology Industry Companies
| Company | Employer Rating |
 |
|
| Microsoft | |
| Cisco Systems | |
| QUALCOMM | |
IndustryTop Rated
